Description

Product Description

Salmon Calcitonin is a 32-amino-acid peptide hormone that plays a pivotal role in calcium homeostasis and bone remodeling. Laboratory research demonstrates that this peptide effectively inhibits osteoclast activity, preventing excessive bone resorption and enhancing calcium deposition in the skeletal system. Its high receptor affinity and potent activity make it indispensable in preclinical studies focused on osteoporosis, Paget’s disease, hypercalcemia of malignancy, and related metabolic disorders.

Research applications include examining the molecular pathways governing bone metabolism, osteoclast differentiation, and signal transduction. Salmon Calcitonin binds selectively to calcitonin receptors on osteoclast membranes, activating the cAMP-PKA pathway. This signaling cascade reduces osteoclast motility, decreases resorptive enzyme secretion, and limits bone matrix degradation. Laboratory studies highlight its modulation of key transcription factors, such as NF-κB, c-Fos, and RANKL, which are critical regulators of osteoclastogenesis.

Beyond bone resorption, Salmon Calcitonin is utilized to investigate calcium homeostasis at systemic levels. It influences renal and intestinal calcium handling, regulating absorption, reuptake, and excretion. Preclinical models also explore its pharmacokinetics, receptor binding kinetics, and peptide stability under various experimental conditions. This research informs dosage optimization and experimental design for bone-targeted therapies.

Salmon Calcitonin Injection is supplied as a lyophilized powder, ensuring long-term stability, high purity, and consistent bioactivity. Researchers can reconstitute the peptide in sterile water or saline for injectable administration in animal models, enabling precise control of dosing and pharmacodynamic studies. Its robust stability profile allows for storage at 2–8°C without significant degradation, supporting reproducible research outcomes over extended periods.

Laboratory studies emphasize its dual role in inhibiting bone resorption while simultaneously promoting bone matrix mineralization. In vitro investigations demonstrate that Salmon Calcitonin suppresses osteoclast fusion and differentiation while enhancing the activity of osteoblasts, indirectly supporting bone formation. Additionally, research into combinatorial effects with anabolic agents such as parathyroid hormone analogs or bisphosphonates reveals synergistic enhancement of bone density in experimental models.

Ongoing preclinical research leverages Salmon Calcitonin to study skeletal aging, bone loss due to hormonal deficiencies, and mechanisms of drug-induced osteopenia. Its capacity to modulate both osteoclast and osteoblast pathways provides a comprehensive tool for mechanistic studies, high-throughput screening of bone-active compounds, and testing of novel peptide delivery platforms.

Studies also investigate the impact of Salmon Calcitonin on calcium signaling pathways within osteocytes, which are essential for mechanotransduction and bone remodeling in response to mechanical stress. Researchers employ this peptide to examine intracellular cAMP dynamics, phosphorylation of CREB, and downstream gene expression that orchestrates bone turnover.

From a pharmacological perspective, Salmon Calcitonin serves as a benchmark molecule in peptide hormone research, enabling exploration of receptor selectivity, half-life extension strategies, and injectable formulation stability. Preclinical investigations assess pharmacokinetics, biodistribution, and peptide-receptor interactions, providing foundational data for the development of bone-targeted therapies.

Product Specifications

Mechanism of Action

Salmon Calcitonin modulates bone metabolism primarily through osteoclast inhibition, but also exerts systemic effects on calcium balance.

1. Osteoclast Inhibition

Salmon Calcitonin binds to calcitonin receptors on osteoclasts, activating intracellular cAMP-PKA signaling, which reduces osteoclast motility, inhibits resorptive enzyme release, and suppresses bone matrix degradation.

2. Calcium Homeostasis Regulation

The peptide decreases serum calcium levels by inhibiting osteoclast-mediated resorption and enhancing renal and intestinal calcium handling, thereby maintaining systemic calcium equilibrium.

3. Intracellular Signaling

Salmon Calcitonin modulates transcription factors such as NF-κB and c-Fos, downregulates RANKL, and affects CREB phosphorylation, collectively suppressing osteoclast differentiation and resorptive activity.

4. Bone Remodeling and Pharmacological Implications

By influencing both osteoclasts and osteoblasts, Salmon Calcitonin supports studies on bone remodeling dynamics, osteoporosis mechanisms, and combinatorial therapeutic strategies in preclinical research.

5. Synergistic Applications

Researchers investigate its synergistic effects with bisphosphonates, parathyroid hormone analogs, and other osteoanabolic agents to explore enhanced bone density and reduced fracture risk in laboratory models.

Side Effects

In laboratory research, Salmon Calcitonin demonstrates minimal cytotoxicity at experimental concentrations. Observed effects include transient modulation of osteoclast morphology and activity.

Experimental handling must comply with biosafety protocols. Variations in solvent, concentration, and pH may impact experimental results. Salmon Calcitonin Injection is strictly for laboratory use and not intended for human or veterinary administration.

Keywords

Salmon Calcitonin Injection, CAS 47931-85-1, peptide hormone, bone metabolism research, osteoporosis study, calcium regulation, osteoclast inhibition, injectable peptide, high-purity peptide, research peptide supplier

Shipping Guarantee

All shipments are handled using validated cold-chain logistics to preserve peptide integrity. Each package is sealed in moisture-proof containers with secondary protective wrapping and continuous temperature monitoring. Products are shipped via express international couriers with full tracking and insurance coverage.

Trade Assurance

We ensure product authenticity, verified ≥99% purity, and compliance with analytical standards (HPLC, MS, and NMR). Each batch is supplied with a Certificate of Analysis (CoA). Our trade assurance policy guarantees replacement or refund for any deviation from listed specifications.

Payment Support

We provide flexible and secure global payment options to support international research transactions. Accepted payment methods include PayPal, major credit cards (Visa, MasterCard, American Express), telegraphic transfer (T/T), and cryptocurrencies (USDT, Bitcoin, Ethereum). All transactions are protected by industry-standard encryption and verified payment gateways to ensure confidentiality and fund security.

Disclaimer

All products listed are intended for laboratory research use only and not for human or veterinary use. They are not drugs, medical devices, or diagnostics and should not be administered to humans or animals. Researchers must handle all materials in accordance with institutional biosafety and chemical safety guidelines. The information provided is for scientific reference only and does not imply therapeutic efficacy, safety, or regulatory approval.